To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03330990
Title Evaluate the Effect of Entrectinib on the Pharmacokinetics of Midazolam in Cancer Patients
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ignyta, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
SCRI-Denver Drug Development Program Denver Colorado 80218 United States Details
Florida Cancer Specialists - Sarasota (North Catttlemen Rd) Sarasota Florida 34232 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field